Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ja Min

Showing results (41-50 of 175) with videos related to

Pageof 18
Sort By:
Scientific Reports|November 16, 2019
Distinctive patterns of peripheral neuropathy across the spectrum of plasma cell disordersJa Min Byun, Young Nam Kwon, Youngil Koh, et al.
International Journal of Systematic and Evolutionary Microbiology|May 10, 2014
Sphingorhabdus arenilitoris sp. nov., isolated from a coastal sand, and reclassification of Sphingopyxis rigui as Sphingorhabdus rigui comb. nov. and Sphingopyxis wooponensis as Sphingorhabdus wooponensis comb. novJa-Min Park, Sooyeon Park, Yong-Taek Jung, et al.
Therapeutic Advances in Hematology|January 6, 2022
Association between preconditioning absolute lymphocyte count and transplant outcomes in patients undergoing matched unrelated donor allogeneic hematopoietic stem cell transplantation with reduced-intensity conditioning and anti-thymocyte globulinJeongmin Seo, Dong-Yeop Shin, Youngil Koh, et al.
Journal of Clinical Medicine|July 29, 2020
Allogeneic Stem Cell Transplantation in Relapsed/Refractory Multiple Myeloma Treatment: Is It Still Relevant? (Running Title: The Role of Salvage alloSCT in MM)Hyunkyung Park, Ja Min Byun, Sung-Soo Yoon, et al.
Oncology Letters|September 20, 2021
Pan-RAF inhibitor LY3009120 is highly synergistic with low-dose cytarabine, but not azacitidine, in acute myeloid leukemia with <i>RAS</i> mutationsJihyun Park, Hyejoo Park, Ja Min Byun, et al.
Therapeutic Advances in Hematology|May 17, 2021
Busulfan plus melphalan <i>versus</i> melphalan alone conditioning regimen after bortezomib based triplet induction chemotherapy for patients with newly diagnosed multiple myelomaSongyi Park, Dong-Yeop Shin, Junshik Hong, et al.
Anticancer Research|May 6, 2020
Characterization and Prognosis of Secondary Acute Myeloid Leukemia in an Asian Population: AML With Antecedent Hematological Disease Confers Worst Outcomes, Irrespective of Cytogenetic RiskSheehyun Kim, Sung-Soo Yoon, Junshik Hong, et al.
RSC Advances|May 6, 2022
Dielectric control of porous polydimethylsiloxane elastomers with Au nanoparticles for enhancing the output performance of triboelectric nanogeneratorsMerreta Noorenza Biutty, Ja Min Koo, Maulida Zakia, et al.
Cytotherapy|April 2, 2026
Role of salvage allogeneic transplantation for relapsed or refractory AML in nonremission: insights from real-world practiceSeungah Cha, Dong-Yeop Shin, Junshik Hong, et al.
Scientific Reports|September 23, 2023
Serum Erythropoietin level in anemia of elderly with unclear etiologyJu Yong Seong, Dong-Yeop Shin, Ja Min Byun, et al.
Pageof 18

Showing results (41-50 of 175) with videos related to

Sort By:
Pageof 18
Scientific Reports|November 16, 2019
Distinctive patterns of peripheral neuropathy across the spectrum of plasma cell disordersJa Min Byun, Young Nam Kwon, Youngil Koh, et al.
International Journal of Systematic and Evolutionary Microbiology|May 10, 2014
Sphingorhabdus arenilitoris sp. nov., isolated from a coastal sand, and reclassification of Sphingopyxis rigui as Sphingorhabdus rigui comb. nov. and Sphingopyxis wooponensis as Sphingorhabdus wooponensis comb. novJa-Min Park, Sooyeon Park, Yong-Taek Jung, et al.
Therapeutic Advances in Hematology|January 6, 2022
Association between preconditioning absolute lymphocyte count and transplant outcomes in patients undergoing matched unrelated donor allogeneic hematopoietic stem cell transplantation with reduced-intensity conditioning and anti-thymocyte globulinJeongmin Seo, Dong-Yeop Shin, Youngil Koh, et al.
Journal of Clinical Medicine|July 29, 2020
Allogeneic Stem Cell Transplantation in Relapsed/Refractory Multiple Myeloma Treatment: Is It Still Relevant? (Running Title: The Role of Salvage alloSCT in MM)Hyunkyung Park, Ja Min Byun, Sung-Soo Yoon, et al.
Oncology Letters|September 20, 2021
Pan-RAF inhibitor LY3009120 is highly synergistic with low-dose cytarabine, but not azacitidine, in acute myeloid leukemia with <i>RAS</i> mutationsJihyun Park, Hyejoo Park, Ja Min Byun, et al.
Therapeutic Advances in Hematology|May 17, 2021
Busulfan plus melphalan <i>versus</i> melphalan alone conditioning regimen after bortezomib based triplet induction chemotherapy for patients with newly diagnosed multiple myelomaSongyi Park, Dong-Yeop Shin, Junshik Hong, et al.
Anticancer Research|May 6, 2020
Characterization and Prognosis of Secondary Acute Myeloid Leukemia in an Asian Population: AML With Antecedent Hematological Disease Confers Worst Outcomes, Irrespective of Cytogenetic RiskSheehyun Kim, Sung-Soo Yoon, Junshik Hong, et al.
RSC Advances|May 6, 2022
Dielectric control of porous polydimethylsiloxane elastomers with Au nanoparticles for enhancing the output performance of triboelectric nanogeneratorsMerreta Noorenza Biutty, Ja Min Koo, Maulida Zakia, et al.
Cytotherapy|April 2, 2026
Role of salvage allogeneic transplantation for relapsed or refractory AML in nonremission: insights from real-world practiceSeungah Cha, Dong-Yeop Shin, Junshik Hong, et al.
Scientific Reports|September 23, 2023
Serum Erythropoietin level in anemia of elderly with unclear etiologyJu Yong Seong, Dong-Yeop Shin, Ja Min Byun, et al.
Pageof 18